Evolv Technologies (NASDAQ:EVLV) Reaches New 1-Year High – Time to Buy?

Evolv Technologies Holdings, Inc. (NASDAQ:EVLVGet Free Report)’s stock price hit a new 52-week high during trading on Friday . The stock traded as high as $5.17 and last traded at $5.04, with a volume of 2616080 shares changing hands. The stock had previously closed at $4.20.

Wall Street Analysts Forecast Growth

Separately, Lake Street Capital raised their price target on shares of Evolv Technologies from $2.75 to $4.00 and gave the company a “hold” rating in a report on Wednesday, April 30th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, Evolv Technologies has a consensus rating of “Hold” and a consensus price target of $5.08.

Get Our Latest Analysis on Evolv Technologies

Evolv Technologies Trading Up 30.0%

The company’s fifty day simple moving average is $3.53 and its 200 day simple moving average is $3.53. The stock has a market capitalization of $892.55 million, a P/E ratio of -39.00 and a beta of 1.61.

Institutional Trading of Evolv Technologies

Several institutional investors and hedge funds have recently made changes to their positions in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of Evolv Technologies by 4.6% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 74,878 shares of the company’s stock valued at $296,000 after buying an additional 3,276 shares in the last quarter. American Century Companies Inc. raised its position in Evolv Technologies by 6.1% in the 1st quarter. American Century Companies Inc. now owns 63,315 shares of the company’s stock worth $198,000 after purchasing an additional 3,633 shares during the period. Mariner LLC raised its position in Evolv Technologies by 15.9% in the 4th quarter. Mariner LLC now owns 26,532 shares of the company’s stock worth $105,000 after purchasing an additional 3,639 shares during the period. MetLife Investment Management LLC raised its position in Evolv Technologies by 5.1% in the 1st quarter. MetLife Investment Management LLC now owns 91,042 shares of the company’s stock worth $284,000 after purchasing an additional 4,412 shares during the period. Finally, JPMorgan Chase & Co. raised its position in Evolv Technologies by 8.5% in the 3rd quarter. JPMorgan Chase & Co. now owns 60,441 shares of the company’s stock worth $245,000 after purchasing an additional 4,756 shares during the period. Hedge funds and other institutional investors own 66.65% of the company’s stock.

About Evolv Technologies

(Get Free Report)

Evolv Technologies Holdings, Inc provides artificial intelligence (AI)-based weapons detection for security screening in the United States and internationally. Its products include Evolv Express, a touchless security screening system designed to detect firearms, improvised explosive devices, and tactical knives; and Evolv Insights that provides self-serve access, insights regarding visitor flow and arrival curves, location specific performance, system detection performance, and alarm statistics.

See Also

Receive News & Ratings for Evolv Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolv Technologies and related companies with MarketBeat.com's FREE daily email newsletter.